259 related articles for article (PubMed ID: 32682189)
1. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group.
Remon J; Nadal E; Dómine M; Ruffinelli J; García Y; Pardo JC; López R; Cilleruelo A; García-Campelo R; Martín P; Juan O; González-Larriba JL; Provencio M; Olmedo E; Ponce S; Cumplido D; Barenys C; Majem M; Massutti B; Rodriguez-Abreu D; Porta R; Sala MA; Martinez-Kareaga M; Lianes P; Reguart N
Lung Cancer; 2020 Sep; 147():83-90. PubMed ID: 32682189
[TBL] [Abstract][Full Text] [Related]
2. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP).
Rojas L; Cardona AF; Trejo-Rosales R; Zatarain-Barrón ZL; Ramírez-Tirado LA; Ruiz-Patiño A; Campos Gómez S; Corrales L; Oblitas G; Bacon L; Martín C; de Lima VCC; Freitas HC; Mas L; Vargas C; Carranza H; Otero J; Pérez MA; González L; Chirinos L; Granados ST; Rodriguez J; Báez R; Remolina Bonilla YA; Núñez Cerrillo G; Archila P; Cuello M; Karachaliou N; Rosell R; Arrieta O;
Thorac Cancer; 2019 Mar; 10(3):508-518. PubMed ID: 30706690
[TBL] [Abstract][Full Text] [Related]
4. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
5. Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes.
Linton A; Soeberg M; Broome R; Kao S; van Zandwijk N
Respirology; 2017 Jul; 22(5):978-985. PubMed ID: 28139858
[TBL] [Abstract][Full Text] [Related]
6. Malignant pleural mesothelioma: a single-center experience in Turkey.
Sezer A; Sümbül AT; Abalı H; Mertsoylu H; Ozyılkan O
Med Sci Monit; 2014 May; 20():825-32. PubMed ID: 24842043
[TBL] [Abstract][Full Text] [Related]
7. [Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition)].
Multidisciplinary Committee of Oncology, Chinese Physicians Association
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):383-394. PubMed ID: 33902201
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data.
Danese MD; Daumont M; Nwokeji E; Gleeson M; Penrod JR; Lubeck D
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1568. PubMed ID: 34698447
[TBL] [Abstract][Full Text] [Related]
9. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
Bou-Samra P; Chang A; Azari F; Kennedy G; Segil A; Guo E; Marmarelis M; Langer C; Singhal S
Cancer Med; 2023 Jun; 12(11):12208-12220. PubMed ID: 37062067
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatment in patients with malignant pleural mesothelioma - real life experience.
Ziółkowska B; Cybulska-Stopa B; Papantoniou D; Suwiński R
BMC Cancer; 2022 Apr; 22(1):432. PubMed ID: 35443624
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients - A Taiwanese study.
Wu TH; Lee LJ; Yuan CT; Chen TW; Yang JC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):230-236. PubMed ID: 29709339
[TBL] [Abstract][Full Text] [Related]
12. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
Saddoughi SA; Abdelsattar ZM; Blackmon SH
Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
14. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
[TBL] [Abstract][Full Text] [Related]
15. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
van Kooten JP; Belderbos RA; von der Thüsen JH; Aarts MJ; Verhoef C; Burgers JA; Baas P; Aalbers AGJ; Maat APWM; Aerts JGJV; Cornelissen R; Madsen EVE
Thorax; 2022 Dec; 77(12):1260-1267. PubMed ID: 35149582
[TBL] [Abstract][Full Text] [Related]
16. [Malignant pleural mesothelioma].
Sritharan SS; Frandsen JL; Omland Ø; Bruun JM
Ugeskr Laeger; 2018 Apr; 180(15):. PubMed ID: 29690982
[TBL] [Abstract][Full Text] [Related]
17. Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).
Raynaud C; Greillier L; Mazieres J; Monnet I; Mastroianni B; Robinet G; Fraboulet G; Dixmier A; Berard H; Lamy R; Letreut J; Lena H; Oliviero G; Botta S; Vergnenegre A; Borget I; Chouaid C
BMC Cancer; 2015 Nov; 15():857. PubMed ID: 26546402
[TBL] [Abstract][Full Text] [Related]
18. Updates in the diagnosis and treatment of malignant pleural mesothelioma.
Katzman D; Sterman DH
Curr Opin Pulm Med; 2018 Jul; 24(4):319-326. PubMed ID: 29553973
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
[TBL] [Abstract][Full Text] [Related]
20. External validation of prognostic indices for overall survival of malignant pleural mesothelioma.
Kataoka Y; Yamamoto Y; Otsuki T; Kaku S; Maehashi-Wada N; Fukuma S; Hirabayashi M; Nakano T; Fukuhara S
Lung Cancer; 2017 Nov; 113():88-92. PubMed ID: 29110856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
